• Keine Ergebnisse gefunden

(1)Supplementary Table S1

N/A
N/A
Protected

Academic year: 2022

Aktie "(1)Supplementary Table S1"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Supplementary Table S1. Primers used for quantitative real-time-PCR.

Gene Forward Primer Reverse Primer

GAPDH GTCTCCTCTGACTTCAACAGCG ACCACCCTGTTGCTGTAGCCAA METTL3 CTATCTCCTGGCACTCGCAAGA GCTTGAACCGTGCAACCACATC METTL14 CTGAAAGTGCCGACAGCATTGG CTCTCCTTCATCCAGATACTTAC

G

FTO CCAGAACCTGAGGAGAGAATGG CGATGTCTGTGAGGTCAAACGG ALKBH5 CCAGCTATGCTTCAGATCGCCT GGTTCTCTTCCTTGTCCATCTCC ALPL GCTGTAAGGACATCGCCTACCA CCTGGCTTTCTCGTCACTCTCA RUNX2 CCCAGTATGAGAGTAGGTGTCC GGGTAAGACTGGTCATAGGACC BGLAP CGCTACCTGTATCAATGGCTGG CTCCTGAAAGCCGATGTGGTCA SPP1 CGAGGTGATAGTGTGGTTTATG

G

GCACCATTCAACTCCTCGCTTTC SP7 TTCTGCGGCAAGAGGTTCACTC GTGTTTGCTCAGGTGGTCGCTT COL1A1 GATTCCCTGGACCTAAAGGTGC AGCCTCTCCATCTTTGCCAGCA VEGFA TTGCCTTGCTGCTCTACCTCCA GATGGCAGTAGCTGCGCTGATA CD44 CCAGAAGGAACAGTGGTTTGGC ACTGTCCTCTGGGCTTGGTGTT MMP2 AGCGAGTGGATGCCGCCTTTAA CATTCCAGGCATCTGCGATGAG HGF GAGAGTTGGGTTCTTACTGCAC

G

CTCATCTCCTCTTCCGTGGACA SPARC TGCCTGATGAGACAGAGGTGGT CTTCGGTTTCCTCTGCACCATC

Referenzen

ÄHNLICHE DOKUMENTE

Abbreviations: M, male; F, female; IgG4-RD, IgG4-related disease; DLBCL, diffuse large B cell lymphoma; MM, multiple myeloma; HL, Hodgkin’s lymphoma; FL, follicular lymphoma;

Supplementary

Frequency of distinct types of imaging tests performed during the first year after the first visit to the pediatric rheumatologist in patients with a complete year of observation

Table S1 Test of autoregressive correlations for the different traits using a linear mixed model with an effect of provenance, block and provenance by block interaction and using

SCLC, small cell lung cancer; LND, lymph node dissected; LNM, lymph node metastasis; NO*, no lymph node dissected.. Supplementary

(((((((((((((((((((((rheumatoid) AND pannus)) OR (((rheumatoid) AND fibroblast) AND synovial)) OR ((rheumatoid) AND purpura)) OR ((rheumatoid) AND vasculitis)) OR ((rheumatoid)

bDMARD, biologic disease-modifying antirheumatic drug; COVID-19, the 2019 novel coronavirus

Kaplan-Meier plot demonstrating 6-month all-cause mortality by timing of cryptococcal antigen (CrAg) testing and outpatient/inpatient status at the time of HIV diagnosis among people